PER 1.23% 8.0¢ percheron therapeutics limited

certainly a favourable/positve article however I amnot fond of...

  1. 2,956 Posts.
    lightbulb Created with Sketch. 116
    certainly a favourable/positve article however I am

    not fond of the following paragraph:

    At the completion of the phase II clinical trial we’d be looking to find partners, but what it also might present is an opportunity for us to raise money and go and complete phase III studies ourselves,” Mr Diamond says, as well as speculating that decent data would make Antisense a takeover target. “That’s something that we will contemplate,” he says.

    Just what we need is more dillution, I can only hope

    if this does occur the SP is sitting around say 10-20cents (unlikely)

    so we don't have to add another 500million shares or

    whatever maybe needed to fund phase III.

    Though knowing ANP and where the SP currently sits we will

    probably still be trading at this ridiculous price of

    1.2 - 1.6 cents range and require massive increase in

    shares simply to go it alone. Time will tell. GLA

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
-0.001(1.23%)
Mkt cap ! $72.12M
Open High Low Value Volume
8.2¢ 8.2¢ 8.0¢ $63.52K 777.8K

Buyers (Bids)

No. Vol. Price($)
2 43377 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 97561 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.